Fig. 3
From: Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40364-016-0064-5/MediaObjects/40364_2016_64_Fig3_HTML.gif)
Kaplan-Meier plots of time to recurrence and overall survival according to IFITM1 expression in patients with M0-disease and no macroscopic residual tumor (R0-1). Time to recurrence in a esophageal cancer, b GE junction cancer, and c gastric cancer. Overall survival in d esophageal cancer, e GE junction cancer, and f gastric cancer